5% stakes
Octagon Capital Advisors
Institution
- 5% stake reports
- 14
- 5% stake stocks
- 8
- Latest report
- 26/07/31
5% stake reports
| Stock | ||
|---|---|---|
| Context Therapeutics CNTX07/31 | 3.3%3,050,000 sh | −2.4pp |
| Context Therapeutics CNTX05/14 | 5.7%5,250,000 sh | First report |
| Corbus Pharmaceuticals Holdings CRBP05/14 | 0%0 sh | −5.4pp |
| Gossamer Bio GOSS05/14 | 3.8%8,976,054 sh | −2.7pp |
| Dianthus Therapeutics DNTH05/14 | 3.6%1,946,667 sh | −2.5pp |
| Gossamer Bio GOSS02/17 | 6.5%15,141,425 sh | −2.1pp |
| Precision Biosciences DTIL02/10 | 9.99%2,328,485 sh | First report |
| Unicycive Therapeutics UNCY02/10 | 4.7%1,000,000 sh | −1.0pp |
| Palisade Bio PALI02/10 | 6.4%9,567,898 sh | First report |
| Unicycive Therapeutics UNCY25/11/14 | 5.7%1,000,000 sh | −2.1pp |
| Taysha Gene Therapies TSHA25/11/14 | 3.3%9,067,500 sh | −1.8pp |
| Dianthus Therapeutics DNTH25/11/14 | 6.1%2,416,667 sh | −1.0pp |
| Gossamer Bio GOSS25/02/05 | 8.6%19,576,054 sh | First report |
| Taysha Gene Therapies TSHA25/02/05 | 5.1%10,450,000 sh | First report |
